Bregondo, Ruth A.
HRN: 14-15-36 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/11/2022
CEFTRIAXONE 1G (VIAL)
11/11/2022
11/17/2022
IV
2G
OD
Intraabdominal Infection
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes